Previous Close | 25.20 |
Open | 25.91 |
Bid | 25.84 x 0 |
Ask | 25.86 x 0 |
Day's Range | 25.91 - 25.94 |
52 Week Range | 23.64 - 37.35 |
Volume | |
Avg. Volume | 595 |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | Jul 30, 2024 - Aug 05, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Competition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.
Insight into the Fund's Latest Investment Decisions and Stock Adjustments
Eli Lilly (LLY), Novo Nordisk (NVO), Pfizer (PFE) and AbbVie (ABBV) announce their first-quarter results.